BioTwin / Solution modalities

What if the right solution is a different way to intervene?

Blocking a protein, removing it and reducing its production can require very different development programs. Compare the biological job each approach could do, then see where BioTwin has computational methods, strategy templates or planned coverage.

Illustration combining a folded protein surface, internal ribbons and fine molecular structure.

Keep the objective. Explore another way to reach it.

The same biological objective can lead to very different interventions. Use the effect you need and the constraint you face to choose which route deserves a closer look.

01 /
Reduce unwanted activity

Explore inhibition, state control or targeted removal. Access, selectivity and recruitment each lead to a different next question.

02 /
Change protein production

Explore transcript-directed or genetic approaches, then examine delivery and expression requirements.

03 /
Restore a missing function

Explore biological replacement, gene delivery or cell-based strategies according to the intended effect.

9 modality classes

Molecular interventions

01 /
Small Molecules

BioTwin small-molecule studies connect pockets, allostery and covalent chemistry to mechanism and exposure questions.

RNA-directed interventions

02 /
Antisense Oligonucleotides

BioTwin antisense strategy templates distinguish transcript knockdown from splice correction; sequence, chemistry and delivery remain program requirements.

05 /
mRNA

Explore BioTwin’s mRNA research direction: protein supply, target cells, expression duration and the requirements for a future design workflow.

Targeted degradation

03 /
PROTACs

Explore BioTwin’s computational E3 recruiter and linker-geometry studies for targeted protein degradation.

Biological molecules

04 /
Biologics

BioTwin strategy modeling for antibodies and protein or enzyme replacement, with related interface and exposure methods.

Genetic interventions

06 /
Gene Therapy

Gene-addition and replacement strategy templates in BioTwin, connecting function and isoform context to expression and delivery requirements.

07 /
CRISPR & Gene Editing

BioTwin’s gene-editing research direction covers causal intervention hypotheses; guide design, off-target analysis and delivery are future workflow requirements.

Cellular interventions

08 /
Cell Therapies

Explore the relationship between BioTwin’s cell-state models and its future cell-therapy direction, including engineering and functional evidence requirements.

Targeted radiation

09 /
Radiopharmaceuticals

BioTwin’s planned radiopharmaceutical coverage: target binding, isotope and chelator selection, distribution and dosimetry requirements.

Start with the change you need in the biology

These nine modality classes organize BioTwin’s solution framework. Current support ranges from selected computational design studies to strategy templates and research directions. Each page makes that scope explicit.

Related formats and mechanisms

Intervention architectures can overlap these classes. The distinction matters to how a mechanism is designed and tested.

Delivery can determine the choice

The same intended effect may need a different approach in a different tissue or compartment. Match delivery questions to the therapeutic format. Small-molecule partitioning, oligonucleotide uptake and vector delivery need different models and evidence.

Compare routes around your target

Describe the biological objective and any modality you are considering. We can discuss relevant scientific work and what a focused evaluation or research collaboration would require.

Discuss a focused scientific evaluation

Tell us the target, the constraint and the decision your team needs to make.